Key result
Continuous Foscarbidopa/Foslevodopa infusion improves symptomatic nOH in a single patient.
Continuous Foscarbidopa/Foslevodopa infusion may be associated with improvement in symptomatic neurogenic orthostatic hypotension.
Answers are grounded in this paper and cite their sources.
Single-case nOH improvement does not support practice change; hypothesis-generating and requires prospective confirmation.
To describe a case where a patient receiving Foscarbidopa/Foslevodopa infusion experienced improvement in symptomatic neurogenic orthostatic hypotension (nOH).
No takes yet. Share an insight, caveat, or question.
Bhushan et al. (2026) studied this question. Continuous Foscarbidopa/Foslevodopa infusion improved symptomatic neurogenic orthostatic hypotension in a single patient case.
Synapse has enriched 10 related papers. Consider them for comparative context: